| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | volume-sensitive anion channel activity | 1.00e-11 | 9 | 50 | 5 | GO:0005225 | |
| GeneOntologyMolecularFunction | monoatomic anion transmembrane transporter activity | 1.22e-10 | 151 | 50 | 9 | GO:0008509 | |
| GeneOntologyMolecularFunction | monoatomic anion channel activity | 1.71e-10 | 103 | 50 | 8 | GO:0005253 | |
| GeneOntologyMolecularFunction | monoatomic ion channel activity | LRRC8E LRRC8C GABRR1 CACNA1E CLCN3 NALCN ANO6 LRRC8A GABRQ LRRC8B | 1.68e-07 | 459 | 50 | 10 | GO:0005216 |
| GeneOntologyMolecularFunction | transporter activity | LRRC8E LRRC8C GABRR1 CACNA1E SLC4A7 ATP8A1 CLCN3 SLC7A13 NALCN ANO6 NPC1L1 LRRC8A GABRQ LRRC8B ATP10D | 3.41e-07 | 1289 | 50 | 15 | GO:0005215 |
| GeneOntologyMolecularFunction | monoatomic ion transmembrane transporter activity | LRRC8E LRRC8C GABRR1 CACNA1E SLC4A7 ATP8A1 CLCN3 NALCN ANO6 LRRC8A GABRQ LRRC8B | 4.28e-07 | 793 | 50 | 12 | GO:0015075 |
| GeneOntologyMolecularFunction | channel activity | LRRC8E LRRC8C GABRR1 CACNA1E CLCN3 NALCN ANO6 LRRC8A GABRQ LRRC8B | 5.79e-07 | 525 | 50 | 10 | GO:0015267 |
| GeneOntologyMolecularFunction | passive transmembrane transporter activity | LRRC8E LRRC8C GABRR1 CACNA1E CLCN3 NALCN ANO6 LRRC8A GABRQ LRRC8B | 5.89e-07 | 526 | 50 | 10 | GO:0022803 |
| GeneOntologyMolecularFunction | transmembrane transporter activity | LRRC8E LRRC8C GABRR1 CACNA1E SLC4A7 ATP8A1 CLCN3 SLC7A13 NALCN ANO6 LRRC8A GABRQ LRRC8B | 4.58e-06 | 1180 | 50 | 13 | GO:0022857 |
| GeneOntologyMolecularFunction | chloride channel activity | 6.35e-05 | 86 | 50 | 4 | GO:0005254 | |
| GeneOntologyMolecularFunction | inorganic anion transmembrane transporter activity | 6.74e-05 | 171 | 50 | 5 | GO:0015103 | |
| GeneOntologyMolecularFunction | signal recognition particle binding | 1.70e-04 | 8 | 50 | 2 | GO:0005047 | |
| GeneOntologyMolecularFunction | ligand-gated monoatomic anion channel activity | 2.67e-04 | 50 | 50 | 3 | GO:0099095 | |
| GeneOntologyMolecularFunction | chloride transmembrane transporter activity | 2.70e-04 | 125 | 50 | 4 | GO:0015108 | |
| GeneOntologyMolecularFunction | intramembrane lipid transporter activity | 2.83e-04 | 51 | 50 | 3 | GO:0140303 | |
| GeneOntologyMolecularFunction | voltage-gated chloride channel activity | 3.33e-04 | 11 | 50 | 2 | GO:0005247 | |
| GeneOntologyMolecularFunction | protein phosphatase activator activity | 8.16e-04 | 17 | 50 | 2 | GO:0072542 | |
| GeneOntologyMolecularFunction | voltage-gated monoatomic anion channel activity | 8.16e-04 | 17 | 50 | 2 | GO:0008308 | |
| GeneOntologyMolecularFunction | flippase activity | 8.16e-04 | 17 | 50 | 2 | GO:0140327 | |
| GeneOntologyMolecularFunction | GABA-gated chloride ion channel activity | 9.16e-04 | 18 | 50 | 2 | GO:0022851 | |
| GeneOntologyMolecularFunction | GABA-A receptor activity | 1.02e-03 | 19 | 50 | 2 | GO:0004890 | |
| GeneOntologyMolecularFunction | phosphatase activator activity | 1.13e-03 | 20 | 50 | 2 | GO:0019211 | |
| GeneOntologyMolecularFunction | GABA receptor activity | 1.37e-03 | 22 | 50 | 2 | GO:0016917 | |
| GeneOntologyMolecularFunction | gated channel activity | 1.45e-03 | 334 | 50 | 5 | GO:0022836 | |
| GeneOntologyMolecularFunction | lipid transporter activity | 1.46e-03 | 196 | 50 | 4 | GO:0005319 | |
| GeneOntologyMolecularFunction | ATPase-coupled intramembrane lipid transporter activity | 2.23e-03 | 28 | 50 | 2 | GO:0140326 | |
| GeneOntologyMolecularFunction | inorganic molecular entity transmembrane transporter activity | 2.66e-03 | 758 | 50 | 7 | GO:0015318 | |
| GeneOntologyMolecularFunction | antiporter activity | 4.99e-03 | 138 | 50 | 3 | GO:0015297 | |
| GeneOntologyBiologicalProcess | monoatomic anion transmembrane transport | 1.04e-10 | 153 | 50 | 9 | GO:0098656 | |
| GeneOntologyBiologicalProcess | monoatomic anion transport | 5.12e-10 | 183 | 50 | 9 | GO:0006820 | |
| GeneOntologyBiologicalProcess | aspartate transmembrane transport | 1.74e-09 | 22 | 50 | 5 | GO:0015810 | |
| GeneOntologyBiologicalProcess | cyclic-GMP-AMP transmembrane import across plasma membrane | 2.12e-09 | 8 | 50 | 4 | GO:0140361 | |
| GeneOntologyBiologicalProcess | guanine nucleotide transmembrane transport | 6.35e-09 | 10 | 50 | 4 | GO:1903790 | |
| GeneOntologyBiologicalProcess | C4-dicarboxylate transport | 7.75e-09 | 29 | 50 | 5 | GO:0015740 | |
| GeneOntologyBiologicalProcess | cyclic nucleotide transport | 9.96e-09 | 11 | 50 | 4 | GO:0070729 | |
| GeneOntologyBiologicalProcess | guanine nucleotide transport | 9.96e-09 | 11 | 50 | 4 | GO:0001408 | |
| GeneOntologyBiologicalProcess | organophosphate ester transport | 1.22e-07 | 162 | 50 | 7 | GO:0015748 | |
| GeneOntologyBiologicalProcess | nucleotide transmembrane transport | 9.16e-07 | 31 | 50 | 4 | GO:1901679 | |
| GeneOntologyBiologicalProcess | monoatomic ion transmembrane transport | LRRC8E LRRC8C GABRR1 CACNA1E SLC4A7 ATP8A1 CLCN3 NALCN ANO6 LRRC8A GABRQ LRRC8B ATP10D | 1.71e-06 | 1115 | 50 | 13 | GO:0034220 |
| GeneOntologyBiologicalProcess | purine-containing compound transmembrane transport | 2.62e-06 | 40 | 50 | 4 | GO:0072530 | |
| GeneOntologyBiologicalProcess | purine ribonucleotide transport | 2.62e-06 | 40 | 50 | 4 | GO:0015868 | |
| GeneOntologyBiologicalProcess | monoatomic ion transport | LRRC8E LRRC8C GABRR1 CACNA1E SLC4A7 ATP8A1 CLCN3 NALCN ANO6 LRRC8A GABRQ TACR2 LRRC8B ATP10D | 3.06e-06 | 1374 | 50 | 14 | GO:0006811 |
| GeneOntologyBiologicalProcess | cell volume homeostasis | 3.19e-06 | 42 | 50 | 4 | GO:0006884 | |
| GeneOntologyBiologicalProcess | adenine nucleotide transport | 3.19e-06 | 42 | 50 | 4 | GO:0051503 | |
| GeneOntologyBiologicalProcess | purine nucleotide transport | 3.86e-06 | 44 | 50 | 4 | GO:0015865 | |
| GeneOntologyBiologicalProcess | inorganic anion transport | 4.70e-06 | 180 | 50 | 6 | GO:0015698 | |
| GeneOntologyBiologicalProcess | nucleotide transport | 6.48e-06 | 50 | 50 | 4 | GO:0006862 | |
| GeneOntologyBiologicalProcess | import into cell | LRRC8E LRRC8C CACNA1E ATP8A1 DENND1B CLCN3 ANO6 LRRC8A LRRC8B FER1L5 DENND1A SORL1 | 7.21e-06 | 1074 | 50 | 12 | GO:0098657 |
| GeneOntologyBiologicalProcess | chloride transmembrane transport | 7.52e-06 | 112 | 50 | 5 | GO:1902476 | |
| GeneOntologyBiologicalProcess | amino acid transmembrane transport | 1.05e-05 | 120 | 50 | 5 | GO:0003333 | |
| GeneOntologyBiologicalProcess | dicarboxylic acid transport | 1.05e-05 | 120 | 50 | 5 | GO:0006835 | |
| GeneOntologyBiologicalProcess | chloride transport | 1.44e-05 | 128 | 50 | 5 | GO:0006821 | |
| GeneOntologyBiologicalProcess | inorganic anion transmembrane transport | 1.80e-05 | 134 | 50 | 5 | GO:0098661 | |
| GeneOntologyBiologicalProcess | regulation of protein exit from endoplasmic reticulum | 3.76e-05 | 27 | 50 | 3 | GO:0070861 | |
| GeneOntologyBiologicalProcess | carboxylic acid transmembrane transport | 4.61e-05 | 163 | 50 | 5 | GO:1905039 | |
| GeneOntologyBiologicalProcess | organic acid transmembrane transport | 5.17e-05 | 167 | 50 | 5 | GO:1903825 | |
| GeneOntologyBiologicalProcess | carbohydrate derivative transport | 8.61e-05 | 96 | 50 | 4 | GO:1901264 | |
| GeneOntologyBiologicalProcess | amino acid transport | 1.08e-04 | 195 | 50 | 5 | GO:0006865 | |
| GeneOntologyBiologicalProcess | alkanesulfonate transmembrane transport | 1.60e-04 | 8 | 50 | 2 | GO:0042918 | |
| GeneOntologyBiologicalProcess | negative regulation of cell volume | 1.60e-04 | 8 | 50 | 2 | GO:0045794 | |
| GeneOntologyBiologicalProcess | taurine transmembrane transport | 1.60e-04 | 8 | 50 | 2 | GO:0015734 | |
| GeneOntologyBiologicalProcess | protein hexamerization | 2.05e-04 | 9 | 50 | 2 | GO:0034214 | |
| GeneOntologyBiologicalProcess | negative regulation of retrograde protein transport, ER to cytosol | 2.05e-04 | 9 | 50 | 2 | GO:1904153 | |
| GeneOntologyBiologicalProcess | import across plasma membrane | 2.32e-04 | 230 | 50 | 5 | GO:0098739 | |
| GeneOntologyBiologicalProcess | negative regulation of protein exit from endoplasmic reticulum | 2.56e-04 | 10 | 50 | 2 | GO:0070862 | |
| GeneOntologyBiologicalProcess | protein exit from endoplasmic reticulum | 2.57e-04 | 51 | 50 | 3 | GO:0032527 | |
| GeneOntologyBiologicalProcess | regulation of lipid kinase activity | 3.12e-04 | 11 | 50 | 2 | GO:0043550 | |
| GeneOntologyBiologicalProcess | phospholipid translocation | 3.22e-04 | 55 | 50 | 3 | GO:0045332 | |
| GeneOntologyBiologicalProcess | positive regulation of synaptic transmission, cholinergic | 3.74e-04 | 12 | 50 | 2 | GO:0032224 | |
| GeneOntologyBiologicalProcess | lipid translocation | 4.16e-04 | 60 | 50 | 3 | GO:0034204 | |
| GeneOntologyBiologicalProcess | regulation of retrograde protein transport, ER to cytosol | 5.14e-04 | 14 | 50 | 2 | GO:1904152 | |
| GeneOntologyBiologicalProcess | sulfur compound transport | 5.27e-04 | 65 | 50 | 3 | GO:0072348 | |
| GeneOntologyBiologicalProcess | regulation of membrane lipid distribution | 5.27e-04 | 65 | 50 | 3 | GO:0097035 | |
| GeneOntologyBiologicalProcess | regulation of synaptic transmission, cholinergic | 7.65e-04 | 17 | 50 | 2 | GO:0032222 | |
| GeneOntologyBiologicalProcess | protein N-linked glycosylation | 8.32e-04 | 76 | 50 | 3 | GO:0006487 | |
| GeneOntologyBiologicalProcess | regulation of intracellular protein transport | 9.84e-04 | 182 | 50 | 4 | GO:0033157 | |
| GeneOntologyBiologicalProcess | endoplasmic reticulum unfolded protein response | 1.15e-03 | 85 | 50 | 3 | GO:0030968 | |
| GeneOntologyBiologicalProcess | organic anion transport | 1.47e-03 | 515 | 50 | 6 | GO:0015711 | |
| GeneOntologyBiologicalProcess | endocytic recycling | 1.59e-03 | 95 | 50 | 3 | GO:0032456 | |
| GeneOntologyBiologicalProcess | cilium movement involved in cell motility | 1.67e-03 | 210 | 50 | 4 | GO:0060294 | |
| GeneOntologyBiologicalProcess | cilium or flagellum-dependent cell motility | 1.82e-03 | 215 | 50 | 4 | GO:0001539 | |
| GeneOntologyBiologicalProcess | cilium-dependent cell motility | 1.82e-03 | 215 | 50 | 4 | GO:0060285 | |
| GeneOntologyBiologicalProcess | cellular response to unfolded protein | 1.84e-03 | 100 | 50 | 3 | GO:0034620 | |
| GeneOntologyCellularComponent | transporter complex | LRRC8E LRRC8C GABRR1 CACNA1E ATP8A1 NALCN ANO6 LRRC8A GABRQ LRRC8B ATP10D | 5.58e-08 | 550 | 50 | 11 | GO:1990351 |
| GeneOntologyCellularComponent | endoplasmic reticulum membrane | LRRC8E LRRC8C YIF1B PIK3R1 ALG14 DERL3 DERL2 LRRC8B FADS2B ZDHHC11 REEP3 HACD1 AWAT1 ATP10D SORL1 | 1.97e-07 | 1293 | 50 | 15 | GO:0005789 |
| GeneOntologyCellularComponent | endoplasmic reticulum subcompartment | LRRC8E LRRC8C YIF1B PIK3R1 ALG14 DERL3 DERL2 LRRC8B FADS2B ZDHHC11 REEP3 HACD1 AWAT1 ATP10D SORL1 | 2.09e-07 | 1299 | 50 | 15 | GO:0098827 |
| GeneOntologyCellularComponent | monoatomic ion channel complex | 2.45e-07 | 378 | 50 | 9 | GO:0034702 | |
| GeneOntologyCellularComponent | nuclear outer membrane-endoplasmic reticulum membrane network | LRRC8E LRRC8C YIF1B PIK3R1 ALG14 DERL3 DERL2 LRRC8B FADS2B ZDHHC11 REEP3 HACD1 AWAT1 ATP10D SORL1 | 2.76e-07 | 1327 | 50 | 15 | GO:0042175 |
| GeneOntologyCellularComponent | transmembrane transporter complex | 3.61e-06 | 523 | 50 | 9 | GO:1902495 | |
| GeneOntologyCellularComponent | chloride channel complex | 3.44e-04 | 57 | 50 | 3 | GO:0034707 | |
| GeneOntologyCellularComponent | phospholipid-translocating ATPase complex | 5.01e-04 | 14 | 50 | 2 | GO:1990531 | |
| GeneOntologyCellularComponent | membrane protein complex | LRRC8E LRRC8C GABRR1 CACNA1E NALCN ANO6 PIK3R1 ALG14 LRRC8A GABRQ LRRC8B | 6.83e-04 | 1498 | 50 | 11 | GO:0098796 |
| GeneOntologyCellularComponent | trans-Golgi network | 8.04e-04 | 306 | 50 | 5 | GO:0005802 | |
| GeneOntologyCellularComponent | protein phosphatase type 2A complex | 8.37e-04 | 18 | 50 | 2 | GO:0000159 | |
| GeneOntologyCellularComponent | GABA-A receptor complex | 9.34e-04 | 19 | 50 | 2 | GO:1902711 | |
| GeneOntologyCellularComponent | GABA receptor complex | 1.14e-03 | 21 | 50 | 2 | GO:1902710 | |
| GeneOntologyCellularComponent | synaptic membrane | 2.57e-03 | 583 | 50 | 6 | GO:0097060 | |
| GeneOntologyCellularComponent | sno(s)RNA-containing ribonucleoprotein complex | 2.66e-03 | 32 | 50 | 2 | GO:0005732 | |
| GeneOntologyCellularComponent | cytoplasmic vesicle membrane | 3.48e-03 | 1307 | 50 | 9 | GO:0030659 | |
| GeneOntologyCellularComponent | vesicle membrane | 3.81e-03 | 1325 | 50 | 9 | GO:0012506 | |
| GeneOntologyCellularComponent | Golgi apparatus subcompartment | 4.04e-03 | 443 | 50 | 5 | GO:0098791 | |
| GeneOntologyCellularComponent | transport vesicle membrane | 5.25e-03 | 293 | 50 | 4 | GO:0030658 | |
| Domain | LRRC8_Pannexin-like | 2.09e-10 | 5 | 49 | 4 | IPR021040 | |
| Domain | Pannexin_like | 2.09e-10 | 5 | 49 | 4 | PF12534 | |
| Domain | DER1 | 2.02e-05 | 3 | 49 | 2 | IPR007599 | |
| Domain | PP2A_B56 | 6.71e-05 | 5 | 49 | 2 | IPR002554 | |
| Domain | B56 | 6.71e-05 | 5 | 49 | 2 | PF01603 | |
| Domain | LRR_5 | 2.99e-04 | 10 | 49 | 2 | PF13306 | |
| Domain | LRR_5 | 2.99e-04 | 10 | 49 | 2 | IPR026906 | |
| Domain | P_typ_ATPase_c | 6.01e-04 | 14 | 49 | 2 | IPR032630 | |
| Domain | P-type_ATPase_N | 6.01e-04 | 14 | 49 | 2 | IPR032631 | |
| Domain | P-type_ATPase_IV | 6.01e-04 | 14 | 49 | 2 | IPR006539 | |
| Domain | PhoLip_ATPase_C | 6.01e-04 | 14 | 49 | 2 | PF16212 | |
| Domain | PhoLip_ATPase_N | 6.01e-04 | 14 | 49 | 2 | PF16209 | |
| Domain | uDENN | 6.01e-04 | 14 | 49 | 2 | SM00800 | |
| Domain | uDENN | 6.93e-04 | 15 | 49 | 2 | PF03456 | |
| Domain | DENN | 7.90e-04 | 16 | 49 | 2 | PF02141 | |
| Domain | UDENN | 7.90e-04 | 16 | 49 | 2 | PS50946 | |
| Domain | DDENN | 7.90e-04 | 16 | 49 | 2 | PS50947 | |
| Domain | dDENN_dom | 7.90e-04 | 16 | 49 | 2 | IPR005112 | |
| Domain | uDENN_dom | 7.90e-04 | 16 | 49 | 2 | IPR005113 | |
| Domain | dDENN | 7.90e-04 | 16 | 49 | 2 | PF03455 | |
| Domain | DENN | 7.90e-04 | 16 | 49 | 2 | SM00799 | |
| Domain | DENN | 7.90e-04 | 16 | 49 | 2 | PS50211 | |
| Domain | DENN_dom | 7.90e-04 | 16 | 49 | 2 | IPR001194 | |
| Domain | dDENN | 7.90e-04 | 16 | 49 | 2 | SM00801 | |
| Domain | LRR_8 | 1.04e-03 | 171 | 49 | 4 | PF13855 | |
| Domain | Leu-rich_rpt_typical-subtyp | 1.18e-03 | 177 | 49 | 4 | IPR003591 | |
| Domain | LRR_TYP | 1.18e-03 | 177 | 49 | 4 | SM00369 | |
| Domain | GABAA/Glycine_rcpt | 1.65e-03 | 23 | 49 | 2 | IPR006028 | |
| Domain | LRR | 1.89e-03 | 201 | 49 | 4 | PS51450 | |
| Domain | LRR_1 | 2.58e-03 | 219 | 49 | 4 | PF00560 | |
| Domain | - | 3.18e-03 | 32 | 49 | 2 | 2.70.150.10 | |
| Domain | - | 3.18e-03 | 32 | 49 | 2 | 3.40.1110.10 | |
| Domain | ATPase_P-typ_cyto_domN | 3.80e-03 | 35 | 49 | 2 | IPR023299 | |
| Domain | ATPase_P-typ_P_site | 4.01e-03 | 36 | 49 | 2 | IPR018303 | |
| Domain | P_typ_ATPase | 4.01e-03 | 36 | 49 | 2 | IPR001757 | |
| Domain | ATPASE_E1_E2 | 4.01e-03 | 36 | 49 | 2 | PS00154 | |
| Domain | ATPase_P-typ_transduc_dom_A | 4.24e-03 | 37 | 49 | 2 | IPR008250 | |
| Domain | E1-E2_ATPase | 4.24e-03 | 37 | 49 | 2 | PF00122 | |
| Domain | Leu-rich_rpt | 5.50e-03 | 271 | 49 | 4 | IPR001611 | |
| Domain | Neurotransmitter_ion_chnl_CS | 6.21e-03 | 45 | 49 | 2 | IPR018000 | |
| Domain | TF_fork_head_CS_2 | 6.48e-03 | 46 | 49 | 2 | IPR030456 | |
| Domain | Neur_chan_memb | 6.48e-03 | 46 | 49 | 2 | PF02932 | |
| Domain | Neur_chan_LBD | 6.76e-03 | 47 | 49 | 2 | PF02931 | |
| Domain | Neur_channel | 6.76e-03 | 47 | 49 | 2 | IPR006201 | |
| Domain | Neur_chan_lig-bd | 6.76e-03 | 47 | 49 | 2 | IPR006202 | |
| Domain | NEUROTR_ION_CHANNEL | 6.76e-03 | 47 | 49 | 2 | PS00236 | |
| Domain | Neurotrans-gated_channel_TM | 6.76e-03 | 47 | 49 | 2 | IPR006029 | |
| Domain | TF_fork_head_CS_1 | 6.76e-03 | 47 | 49 | 2 | IPR018122 | |
| Domain | - | 6.76e-03 | 47 | 49 | 2 | 2.70.170.10 | |
| Domain | FORK_HEAD_3 | 7.33e-03 | 49 | 49 | 2 | PS50039 | |
| Domain | FH | 7.33e-03 | 49 | 49 | 2 | SM00339 | |
| Domain | FORK_HEAD_1 | 7.33e-03 | 49 | 49 | 2 | PS00657 | |
| Domain | FORK_HEAD_2 | 7.33e-03 | 49 | 49 | 2 | PS00658 | |
| Domain | Forkhead | 7.33e-03 | 49 | 49 | 2 | PF00250 | |
| Domain | Fork_head_dom | 7.33e-03 | 49 | 49 | 2 | IPR001766 | |
| Pathway | REACTOME_MISCELLANEOUS_TRANSPORT_AND_BINDING_EVENTS | 8.23e-07 | 25 | 42 | 4 | MM15172 | |
| Pathway | REACTOME_MISCELLANEOUS_TRANSPORT_AND_BINDING_EVENTS | 9.70e-07 | 26 | 42 | 4 | M27424 | |
| Pathway | REACTOME_TRANSPORT_OF_SMALL_MOLECULES | LRRC8E LRRC8C SLC4A7 ATP8A1 CLCN3 NALCN ANO6 DERL3 DERL2 LRRC8A LRRC8B ATP10D | 9.74e-07 | 736 | 42 | 12 | M27287 |
| Pathway | REACTOME_TRANSPORT_OF_SMALL_MOLECULES | LRRC8E LRRC8C SLC4A7 ATP8A1 NALCN ANO6 DERL3 DERL2 LRRC8A LRRC8B ATP10D | 3.35e-06 | 681 | 42 | 11 | MM14985 |
| Pathway | REACTOME_ION_CHANNEL_TRANSPORT | 2.01e-04 | 183 | 42 | 5 | M997 | |
| Pubmed | Renal Deletion of LRRC8/VRAC Channels Induces Proximal Tubulopathy. | 1.89e-11 | 5 | 50 | 4 | 35777784 | |
| Pubmed | LRRC8 involved in B cell development belongs to a novel family of leucine-rich repeat proteins. | 1.89e-11 | 5 | 50 | 4 | 15094057 | |
| Pubmed | 1.89e-11 | 5 | 50 | 4 | 24790029 | ||
| Pubmed | 1.85e-09 | 12 | 50 | 4 | 32277911 | ||
| Pubmed | LRRC8 Proteins Form Volume-Regulated Anion Channels that Sense Ionic Strength. | 1.12e-08 | 4 | 50 | 3 | 26824658 | |
| Pubmed | 1.12e-08 | 4 | 50 | 3 | 28193731 | ||
| Pubmed | LRRC8A:C/E Heteromeric Channels Are Ubiquitous Transporters of cGAMP. | 1.12e-08 | 4 | 50 | 3 | 33171122 | |
| Pubmed | Phosphorylation-dependent Regulation of Connecdenn/DENND1 Guanine Nucleotide Exchange Factors. | 2.03e-06 | 2 | 50 | 2 | 26055712 | |
| Pubmed | 2.03e-06 | 2 | 50 | 2 | 33139539 | ||
| Pubmed | Structure of a volume-regulated anion channel of the LRRC8 family. | 2.03e-06 | 2 | 50 | 2 | 29769723 | |
| Pubmed | Structure of a volume-regulated heteromeric LRRC8A/C channel. | 2.03e-06 | 2 | 50 | 2 | 36522427 | |
| Pubmed | 6.07e-06 | 3 | 50 | 2 | 20154091 | ||
| Pubmed | 1.21e-05 | 4 | 50 | 2 | 11929880 | ||
| Pubmed | Derlin-3 Is Required for Changes in ERAD Complex Formation under ER Stress. | 1.21e-05 | 4 | 50 | 2 | 32858914 | |
| Pubmed | 1.21e-05 | 4 | 50 | 2 | 8702385 | ||
| Pubmed | A membrane protein required for dislocation of misfolded proteins from the ER. | 1.21e-05 | 4 | 50 | 2 | 15215855 | |
| Pubmed | 2.02e-05 | 5 | 50 | 2 | 15095873 | ||
| Pubmed | 2.02e-05 | 5 | 50 | 2 | 8694763 | ||
| Pubmed | Derlin-dependent accumulation of integral membrane proteins at cell surfaces. | 2.02e-05 | 5 | 50 | 2 | 19509052 | |
| Pubmed | 2.02e-05 | 5 | 50 | 2 | 8812429 | ||
| Pubmed | 2.02e-05 | 5 | 50 | 2 | 16449189 | ||
| Pubmed | 2.02e-05 | 5 | 50 | 2 | 9321431 | ||
| Pubmed | An Arf/Rab cascade controls the growth and invasiveness of glioblastoma. | 3.03e-05 | 6 | 50 | 2 | 33443570 | |
| Pubmed | 3.82e-05 | 1168 | 50 | 9 | 19946888 | ||
| Pubmed | 4.23e-05 | 7 | 50 | 2 | 8703017 | ||
| Pubmed | Identification of a new family of protein phosphatase 2A regulatory subunits. | 4.23e-05 | 7 | 50 | 2 | 7592815 | |
| Pubmed | 5.64e-05 | 8 | 50 | 2 | 17245430 | ||
| Pubmed | 5.64e-05 | 8 | 50 | 2 | 26565908 | ||
| Pubmed | 5.64e-05 | 8 | 50 | 2 | 29743537 | ||
| Pubmed | 7.25e-05 | 9 | 50 | 2 | 20435896 | ||
| Pubmed | Gp78 cooperates with RMA1 in endoplasmic reticulum-associated degradation of CFTRDeltaF508. | 7.25e-05 | 9 | 50 | 2 | 18216283 | |
| Pubmed | 7.25e-05 | 9 | 50 | 2 | 30595372 | ||
| Pubmed | Direct binding between BubR1 and B56-PP2A phosphatase complexes regulate mitotic progression. | 7.25e-05 | 9 | 50 | 2 | 23345399 | |
| Pubmed | 9.05e-05 | 10 | 50 | 2 | 15919184 | ||
| Pubmed | 9.05e-05 | 10 | 50 | 2 | 12351180 | ||
| Pubmed | 1.32e-04 | 12 | 50 | 2 | 15380617 | ||
| Pubmed | 1.32e-04 | 12 | 50 | 2 | 21914794 | ||
| Pubmed | Protein phosphatase 2A protects centromeric sister chromatid cohesion during meiosis I. | 1.32e-04 | 12 | 50 | 2 | 16541024 | |
| Pubmed | 1.56e-04 | 13 | 50 | 2 | 21072166 | ||
| Pubmed | Direct activation of protein phosphatase-2A0 by HIV-1 encoded protein complex NCp7:vpr. | 1.82e-04 | 14 | 50 | 2 | 9013886 | |
| Pubmed | 1.82e-04 | 14 | 50 | 2 | 9400615 | ||
| Pubmed | 1.82e-04 | 14 | 50 | 2 | 16048649 | ||
| Pubmed | 2.10e-04 | 15 | 50 | 2 | 23901111 | ||
| Pubmed | 2.20e-04 | 81 | 50 | 3 | 22723691 | ||
| Pubmed | 2.72e-04 | 17 | 50 | 2 | 17266553 | ||
| Pubmed | [Action of protein phosphatase-1 on Tat-dependent HIV-1 transcription and its related inhibitors]. | 2.72e-04 | 17 | 50 | 2 | 21351466 | |
| Pubmed | 3.05e-04 | 18 | 50 | 2 | 23287597 | ||
| Pubmed | 3.05e-04 | 18 | 50 | 2 | 19078961 | ||
| Pubmed | Shugoshin collaborates with protein phosphatase 2A to protect cohesin. | 3.41e-04 | 19 | 50 | 2 | 16541025 | |
| Pubmed | 3.41e-04 | 19 | 50 | 2 | 25660456 | ||
| Pubmed | 4.03e-04 | 952 | 50 | 7 | 38569033 | ||
| Pubmed | 6.44e-04 | 26 | 50 | 2 | 11531413 | ||
| Pubmed | 8.02e-04 | 29 | 50 | 2 | 15071553 | ||
| Pubmed | 8.69e-04 | 1084 | 50 | 7 | 11544199 | ||
| Pubmed | 9.19e-04 | 132 | 50 | 3 | 26439863 | ||
| Pubmed | 9.77e-04 | 32 | 50 | 2 | 17540176 | ||
| Pubmed | 9.77e-04 | 32 | 50 | 2 | 23049088 | ||
| Pubmed | Family-wide characterization of the DENN domain Rab GDP-GTP exchange factors. | 1.31e-03 | 37 | 50 | 2 | 20937701 | |
| Pubmed | Systematic Analysis of Human Protein Phosphatase Interactions and Dynamics. | 1.37e-03 | 573 | 50 | 5 | 28330616 | |
| Interaction | LRRC8B interactions | 1.40e-08 | 33 | 48 | 5 | int:LRRC8B | |
| Interaction | LGALS8 interactions | 1.73e-07 | 174 | 48 | 7 | int:LGALS8 | |
| Interaction | TTYH1 interactions | 4.94e-07 | 300 | 48 | 8 | int:TTYH1 | |
| Interaction | OR10H2 interactions | 7.68e-07 | 72 | 48 | 5 | int:OR10H2 | |
| Interaction | LGALS9B interactions | 3.93e-06 | 45 | 48 | 4 | int:LGALS9B | |
| Interaction | HCST interactions | 8.85e-06 | 205 | 48 | 6 | int:HCST | |
| Interaction | POPDC2 interactions | 2.17e-05 | 23 | 48 | 3 | int:POPDC2 | |
| Interaction | NPEPPS interactions | 6.23e-05 | 177 | 48 | 5 | int:NPEPPS | |
| Cytoband | 1p22.2 | 4.32e-04 | 28 | 50 | 2 | 1p22.2 | |
| GeneFamily | Volume regulated anion channel subunits | 9.23e-11 | 5 | 39 | 4 | 1158 | |
| GeneFamily | Rhomboid family | 4.06e-04 | 14 | 39 | 2 | 926 | |
| GeneFamily | WD repeat domain containing|Protein phosphatase 2 regulatory subunits | 4.68e-04 | 15 | 39 | 2 | 696 | |
| GeneFamily | ATPase phospholipid transporting | 4.68e-04 | 15 | 39 | 2 | 1210 | |
| GeneFamily | Gamma-aminobutyric acid type A receptor subunits | 7.58e-04 | 19 | 39 | 2 | 563 | |
| GeneFamily | Guanylate cyclase receptors|DENN/MADD domain containing | 1.32e-03 | 25 | 39 | 2 | 504 | |
| GeneFamily | Forkhead boxes | 3.87e-03 | 43 | 39 | 2 | 508 | |
| CoexpressionAtlas | dev lower uro neuro_e15.5_PelvicGanglion_Sox10_top-relative-expression-ranked_1000 | LRRC8C CACNA1E ATP8A1 NOP56 NALCN UNC5C GPR63 CLVS1 C18orf32 | 2.81e-05 | 734 | 47 | 9 | gudmap_dev lower uro neuro_e15.5_PelvicGanglion_Sox10_1000 |
| ToppCell | 5'-Adult-LymphNode-Hematopoietic-T_cells-CX3CR1+_CD8_Tmem|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 4.43e-05 | 175 | 50 | 4 | dddeced0cfcf71d03bcf349983908b3bfb0ab51d | |
| ToppCell | Control-T_cells|Control / group, cell type (main and fine annotations) | 5.73e-05 | 187 | 50 | 4 | f4e8e0eba58da89b56587667555a5d4754e108c7 | |
| ToppCell | COPD-Lymphoid-T_Cytotoxic|Lymphoid / Disease state, Lineage and Cell class | 6.10e-05 | 190 | 50 | 4 | 10bece40d980d37a01dae8ce887655bf9f93040c | |
| ToppCell | 3'_v3-bone_marrow-Lymphocytic_T_CD8|bone_marrow / Manually curated celltypes from each tissue | 6.10e-05 | 190 | 50 | 4 | be281c7c717c11ef3c5cbccd22628acf1bd9727f | |
| ToppCell | IPF-Lymphoid-T|IPF / Disease state, Lineage and Cell class | 6.10e-05 | 190 | 50 | 4 | d57df208aaf7a5554899bb9107c80b443fd0cf93 | |
| ToppCell | Globus_pallidus-Neuronal-Inhibitory-iN2(Gad1Gad2)-Inhibitory_Neuron.Gad1Gad2.Vip_(ventral_GP_(vGP))|Globus_pallidus / BrainAtlas - Mouse McCarroll V32 | 6.15e-05 | 68 | 50 | 3 | ad6c363d7fb3c436e894db30a544748c5df75a45 | |
| ToppCell | Globus_pallidus-Neuronal-Inhibitory-iN2(Gad1Gad2)-Inhibitory_Neuron.Gad1Gad2.Vip_(ventral_GP_(vGP))--|Globus_pallidus / BrainAtlas - Mouse McCarroll V32 | 6.15e-05 | 68 | 50 | 3 | 82d928f5eefa065d26096a84b0d78f131dcc8c73 | |
| ToppCell | Globus_pallidus-Neuronal-Inhibitory-iN2(Gad1Gad2)-Inhibitory_Neuron.Gad1Gad2.Vip_(ventral_GP_(vGP))-|Globus_pallidus / BrainAtlas - Mouse McCarroll V32 | 6.15e-05 | 68 | 50 | 3 | d97199a8c6afa79bff1600f00c2dbf6286df24a2 | |
| ToppCell | COVID-19-T_cells-CD4+_T_cells|COVID-19 / group, cell type (main and fine annotations) | 6.22e-05 | 191 | 50 | 4 | 0646cca78e24aeb6baa9934d3c439b797c567997 | |
| ToppCell | COPD-Lymphoid-T|World / Disease state, Lineage and Cell class | 6.35e-05 | 192 | 50 | 4 | eb4909574fb5fc91399463523e2737095773200a | |
| ToppCell | COPD-Lymphoid-T_Cytotoxic|COPD / Disease state, Lineage and Cell class | 6.48e-05 | 193 | 50 | 4 | 58e94fe2e89cdafc6974938f97a4c162061a437d | |
| ToppCell | 5'-Adult-SmallIntestine-Hematopoietic-T_cells-TRGV2_gdT|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 6.48e-05 | 193 | 50 | 4 | 544de0988510cc57744710d7cafe07aa27a0b99d | |
| ToppCell | 10x_3'_v3-thymus_(10x_3'_v3)-lymphocytic-T_lymphocytic-CD8-positive,_alpha-beta_T_cell|thymus_(10x_3'_v3) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type | 6.48e-05 | 193 | 50 | 4 | a594f89a18273797506287d9e22f72abe53e4920 | |
| ToppCell | BALF-PFMC-Severe-critical_progression_d12-22_no-steroids-Lymphocytic-Lymphocytic_T-CD8-positive,_alpha-beta_T_cell|Severe-critical_progression_d12-22_no-steroids / Compartment, severity and other cell annotations on 10x 3' data (130k) | 6.48e-05 | 193 | 50 | 4 | 00349d176fb6a46cbcc99c41d975651b6e9aaad4 | |
| ToppCell | IPF-Lymphoid-T_Cytotoxic|Lymphoid / Disease state, Lineage and Cell class | 6.48e-05 | 193 | 50 | 4 | 3c8a022dbd4f8d25b14fd137ce64c2713a7dbe41 | |
| ToppCell | Smart-seq2-bone_marrow_(Smart-seq2)-lymphocytic-T_lymphocytic-CD8-positive,_alpha-beta_T_cell|bone_marrow_(Smart-seq2) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type | 6.61e-05 | 194 | 50 | 4 | bf2480acec5612cd8a3c33d3e7a98176dc6c9091 | |
| ToppCell | Smart-seq2-tissue-resident_(Smart-seq2)-lymphocytic-T_lymphocytic-T_cell|tissue-resident_(Smart-seq2) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type | 6.88e-05 | 196 | 50 | 4 | 4a880a5d2c7047c050c7d6dd62186f35dc5c01f7 | |
| ToppCell | Bronchial_Brush-Epithelial-Club|Bronchial_Brush / Tissue, Lineage and Cell class of Lung Cells from 10X | 7.15e-05 | 198 | 50 | 4 | 61292a2b5aacb6080a679a31b70a211bdec59a3b | |
| ToppCell | 10x_3'_v3-spleen_(10x_3'_v3)-lymphocytic-T_lymphocytic-naive_thymus-derived_CD8-positive,_alpha-beta_T_cell|spleen_(10x_3'_v3) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type | 7.29e-05 | 199 | 50 | 4 | db05c16d80f5a74bfa048a5c92917d312d26f769 | |
| ToppCell | Bronchial_Brush-Epithelial-Club|Epithelial / Tissue, Lineage and Cell class of Lung Cells from 10X | 7.29e-05 | 199 | 50 | 4 | 53b87edccc89a3e8a6c5166472f9ef24fcba416c | |
| ToppCell | PBMC-Control-Myeloid-Neutrophil-Neutrophil-Neu_0|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09) | 4.00e-04 | 128 | 50 | 3 | 9b3c57d559a5ed8d590dd89b64a57a3227d8c684 | |
| ToppCell | PBMC-Control-Myeloid-Neutrophil-Neutrophil-Neu_0|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 4.00e-04 | 128 | 50 | 3 | 58639cfdc70ff6764adcc5c1ce9eba9d033b8209 | |
| ToppCell | 3'_v3-blood-Lymphocytic_T_CD4-T_CD4/CD8|blood / Manually curated celltypes from each tissue | 4.67e-04 | 135 | 50 | 3 | ae2d3a42e567b5bade304c0caa497eb725be3565 | |
| ToppCell | BALF-PFMC-Severe-critical_progression_d12-22_no-steroids-Lymphocytic-Lymphocytic_T-CD8-positive,_alpha-beta_T_cell-T_CD8_c02-GPR183|Severe-critical_progression_d12-22_no-steroids / Compartment, severity and other cell annotations on 10x 3' data (130k) | 5.19e-04 | 140 | 50 | 3 | 7b359bfbd404ab06d799048252f4985d85852048 | |
| ToppCell | 356C-Lymphocytic-CD8+_Cytotoxic_T-cell-CD8+_Cytotoxic_T_cell_4|356C / Donor, Lineage, Cell class and subclass (all cells) | 5.52e-04 | 143 | 50 | 3 | e8fc6540a48086f58bc3f42dabe392ef46715b9e | |
| ToppCell | Posterior_cortex-Neuronal-Excitatory-eN1(Slc17a7)-eN1_1-Bcl6|Posterior_cortex / BrainAtlas - Mouse McCarroll V32 | 5.64e-04 | 144 | 50 | 3 | 08005be9e3367f78ef27e125d9cce5ca53f4bd2d | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Mesenchymal-glomerular_mesenchymal_cell-Mesangial_Cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 6.10e-04 | 148 | 50 | 3 | f85dc34f6a4a15ecffa4fbd5644dea12ce30089b | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Mesenchymal-glomerular_mesenchymal_cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 6.10e-04 | 148 | 50 | 3 | 4b1fdf90c585f89cee1cf521db4e3fafc9d74d9a | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Mesenchymal-glomerular_mesenchymal_cell-Mesangial_Cell-mesangial_typical-aged|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 6.10e-04 | 148 | 50 | 3 | 55826b7e9f79ab78a93abd4fc662bc37aa121471 | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Mesenchymal-glomerular_mesenchymal_cell-Mesangial_Cell-mesangial_typical|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 6.35e-04 | 150 | 50 | 3 | 8645b9c7f9511ed6cc9afe04440c2873a3094150 | |
| ToppCell | 343B-Lymphocytic-CD8+_Cytotoxic_T-cell-CD8+_Cytotoxic_T_cell_0|343B / Donor, Lineage, Cell class and subclass (all cells) | 6.47e-04 | 151 | 50 | 3 | 78475027bba9e3026e42493fec8ea630972353bb | |
| ToppCell | BALF-PFMC-Severe-critical_progression_d12-22_no-steroids-Lymphocytic-Lymphocytic_ILC|Severe-critical_progression_d12-22_no-steroids / Compartment, severity and other cell annotations on 10x 3' data (130k) | 7.24e-04 | 157 | 50 | 3 | 170197b76620df31495f1247f365da382b2d8045 | |
| ToppCell | 3'_v3-Lung-Lymphocytic_T_CD4/8-lo-Tgd_CRTAM|Lung / Manually curated celltypes from each tissue | 7.24e-04 | 157 | 50 | 3 | af6eb2214340847bbab7cb209ea27cdc83b62a27 | |
| ToppCell | 356C-Lymphocytic-CD8+_Cytotoxic_T-cell|Lymphocytic / Donor, Lineage, Cell class and subclass (all cells) | 7.24e-04 | 157 | 50 | 3 | f2bc60ec0305b056d79f1b7fd6b5e3730d606916 | |
| ToppCell | BALF-PFMC-Severe-critical_progression_d12-22_no-steroids-Lymphocytic-Lymphocytic_ILC-NK_cell|Severe-critical_progression_d12-22_no-steroids / Compartment, severity and other cell annotations on 10x 3' data (130k) | 7.24e-04 | 157 | 50 | 3 | c21520301cc0d5d4b1cc4b8ec735f9adb698e768 | |
| ToppCell | facs-GAT-Fat-24m|GAT / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.24e-04 | 157 | 50 | 3 | c4a0b6c95d353691fd2846002ce4bc7c2b0edd1c | |
| ToppCell | BALF-PFMC-Severe-critical_progression_d12-22_no-steroids-Lymphocytic-Lymphocytic_ILC-NK_cell-NK_c01-FCGR3A|Severe-critical_progression_d12-22_no-steroids / Compartment, severity and other cell annotations on 10x 3' data (130k) | 7.38e-04 | 158 | 50 | 3 | 7274f020c0ecf216da4b6689c62bc5f49c29b6f3 | |
| ToppCell | facs-Limb_Muscle-ForelimbandHindlimb-24m-Lymphocytic-B_cell|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.65e-04 | 160 | 50 | 3 | 6bafbe2b4b98bc088406a516d079093f89d9c344 | |
| ToppCell | 390C-Fibroblasts-Fibroblast-B_(Myofibroblast)-|Fibroblasts / Donor, Lineage, Cell class and subclass (all cells) | 7.65e-04 | 160 | 50 | 3 | 636127753e3a22831f39d4c8170df40901e4329d | |
| ToppCell | 390C-Fibroblasts-Fibroblast-B_(Myofibroblast)|Fibroblasts / Donor, Lineage, Cell class and subclass (all cells) | 7.65e-04 | 160 | 50 | 3 | cb8d0dc1a6c69c7a85c5fdd8f0f6cca1b73dfc63 | |
| ToppCell | TCGA-Brain-Primary_Tumor-Low_Grade_Glioma-Oligoastrocytoma|TCGA-Brain / Sample_Type by Project: Shred V9 | 7.79e-04 | 161 | 50 | 3 | 347edb0de10850b7d16c40945751033289289c9b | |
| ToppCell | Influenza_Severe-Neutrophil|Influenza_Severe / Disease group and Cell class | 7.79e-04 | 161 | 50 | 3 | 98c95b1b85d5427415af2ca8fb14849e97f6e8b5 | |
| ToppCell | droplet-Liver-Hepatocytes-24m-Myeloid-Kupffer_cell|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 8.07e-04 | 163 | 50 | 3 | 8dc0128eeede933537e3bcc5d6ec0322711552f3 | |
| ToppCell | PBMC_fresh-frozen-Severe-critical_progression_d12-22_no-steroids-Lymphocytic-Lymphocytic_T-mature_alpha-beta_T_cell-T_CD4_c02-AQP3|Severe-critical_progression_d12-22_no-steroids / Compartment, severity and other cell annotations on 10x 3' data (130k) | 8.07e-04 | 163 | 50 | 3 | 9195051d6bcdd450ed745a099828a0d76d9d3f0b | |
| ToppCell | droplet-Liver-Hepatocytes-24m-Myeloid-Kupffer_cell|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 8.07e-04 | 163 | 50 | 3 | fd243ca223079033be480a24817a399f281fa4d4 | |
| ToppCell | severe_influenza-CD4+_CTL|severe_influenza / disease group, cell group and cell class (v2) | 8.81e-04 | 168 | 50 | 3 | 50697fda702a09d9a621e9f79c2b52d53792dd2a | |
| ToppCell | 390C-Lymphocytic-CD4_T-cell-CD4+_Effector_T_cell-2|390C / Donor, Lineage, Cell class and subclass (all cells) | 8.96e-04 | 169 | 50 | 3 | cfc9ff103d13a2d5eacc457e800f53fdd29f7738 | |
| ToppCell | Influenza_Severe-Neutrophil|World / Disease group and Cell class | 8.96e-04 | 169 | 50 | 3 | 6e8e2580e19c96bcf7fa6a6d8c183df65f428396 | |
| ToppCell | saliva-Mild-Moderate_progression_d12-25-Lymphocytic-Lymphocytic_B-B_cell-B_c04-SOX5-TNFRSF1B|Mild-Moderate_progression_d12-25 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 9.12e-04 | 170 | 50 | 3 | 32917888c3f1d54302675c1d4de1fd3b7c79af5f | |
| ToppCell | 3'_v3-Lung-Lymphocytic_T_CD4/8-lo|Lung / Manually curated celltypes from each tissue | 9.27e-04 | 171 | 50 | 3 | dfd4a15ab68ef5a9a1954b1b1540ae04017885a6 | |
| ToppCell | facs|World / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 9.27e-04 | 171 | 50 | 3 | c9990bc041a632b2f7bbebbfe737772c423d7027 | |
| ToppCell | normal-na-Lymphocytic_T-T4_em-male|normal / PBMC cell types (v2) per disease, treatment status, and sex | 9.27e-04 | 171 | 50 | 3 | 61318a7aaf3bd8bdd28f8a8614ab4fdf2964b3a3 | |
| ToppCell | saliva-Severe-critical_progression_d12-22_with-steroid-Myeloid-Granulocytic|Severe-critical_progression_d12-22_with-steroid / Compartment, severity and other cell annotations on 10x 3' data (130k) | 9.27e-04 | 171 | 50 | 3 | 2b7c5a557c4bc5c573211c4d618bdd6766a24916 | |
| ToppCell | saliva-Severe-critical_progression_d12-22_with-steroid-Myeloid-Granulocytic-Neutrophil|Severe-critical_progression_d12-22_with-steroid / Compartment, severity and other cell annotations on 10x 3' data (130k) | 9.27e-04 | 171 | 50 | 3 | dcb15bc54aeea06ef8f07f1134f3ff1e21ac0e4f | |
| ToppCell | BAL-Severe-Myeloid-Neutrophil-Neutrophil-Neu_3|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09) | 9.59e-04 | 173 | 50 | 3 | 1edef5aeab626cbf2c09468e77b02cfa2d21ba03 | |
| ToppCell | kidney_cells-Adult_normal_reference-Epithelial-Distal_tubule_epithelial_cell-kidney_distal_convoluted_tubule_epithelial_cell-Distal_Convoluted_Tubule_Cell_Type_1|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 9.59e-04 | 173 | 50 | 3 | 0c74bdb40e635d906fd180412c23bf7fed61621e | |
| ToppCell | BAL-Severe-Myeloid-Neutrophil-Neutrophil|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09) | 9.59e-04 | 173 | 50 | 3 | c37dba3804df7c3151e18e6ae4e0b6e7a92bae97 | |
| ToppCell | ILEUM-inflamed-(1)_T_(gd)|inflamed / shred on tissue, inflammation_status, cell class(v3), cell subclass (v2) | 9.59e-04 | 173 | 50 | 3 | 85c3e227c81c6ab70148639381389fba3ac5e088 | |
| ToppCell | BAL-Severe-Myeloid-Neutrophil|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09) | 9.59e-04 | 173 | 50 | 3 | 5b76d9cc56bbb29017e64a2d0a3c76c0be003d96 | |
| ToppCell | BAL-Severe-Myeloid-Neutrophil-Neutrophil-Neu_3|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 9.59e-04 | 173 | 50 | 3 | bf685025961e79b379f2c35464b6c8ce3e31ace0 | |
| ToppCell | droplet-Trachea-3m-Endothelial-endothelial_cell_of_trachea-tracheal_endothelial_cell-tracheal_endothelial_cell_28|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 9.59e-04 | 173 | 50 | 3 | 66488d01e03264fb193285470901c9c4182fbae8 | |
| ToppCell | BAL-Severe-Myeloid-Neutrophil|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 9.59e-04 | 173 | 50 | 3 | a6e73a40b0d5356564a594053e772f9d061a5919 | |
| ToppCell | severe_influenza-Neutrophil|severe_influenza / disease group, cell group and cell class (v2) | 9.59e-04 | 173 | 50 | 3 | 615e266419b9f06e964eff73cb466f05451ba0dd | |
| ToppCell | BAL-Severe-Myeloid-Neutrophil-Neutrophil|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 9.59e-04 | 173 | 50 | 3 | a8b5370f4c893a20c58e97659f3ac168699693f8 | |
| ToppCell | primary_auditory_cortex_(A1C)-Neuronal-Glutamatergic_Excit-Glut_E_(THEMIS)|primary_auditory_cortex_(A1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 9.75e-04 | 174 | 50 | 3 | bc978a2148a0261a4f9d1ca5479b707e224566be | |
| ToppCell | Healthy-Plasmablast|World / disease group, cell group and cell class | 9.75e-04 | 174 | 50 | 3 | 6becb456d8f44a1224c6d42be78d4c8cdb51f199 | |
| ToppCell | severe_influenza-Neutrophil|World / disease group, cell group and cell class (v2) | 9.75e-04 | 174 | 50 | 3 | f9f07436b7d3f190800cd85d229f007032f391e1 | |
| ToppCell | 10x_3'_v2v3-Non-neoplastic-Lymphoid-CD4/CD8-CD8_cytotoxic-D|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 9.91e-04 | 175 | 50 | 3 | a3f8c54c77bce9b035a4835945ab341909be4946 | |
| ToppCell | COPD-Lymphoid-ILC_A|World / Disease state, Lineage and Cell class | 9.91e-04 | 175 | 50 | 3 | e773e330de36f8a0aa9398a176ed7edb5599c582 | |
| ToppCell | 3'-Parenchyma_lung-Immune_Lymphocytic-Lymphocytic_T/NK-CD8-positive,_alpha-beta_T_cell-CD8_T_cells-CD8_T_cells_L.1.1.0.4|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.01e-03 | 176 | 50 | 3 | ce85a13e10cf37f5cf38ca8b0bac6701b6d00ffd | |
| ToppCell | kidney_cells-Renal_AKI_(acute_kidney_injury)-Epithelial-Distal_tubule_epithelial_cell-kidney_distal_convoluted_tubule_epithelial_cell-Distal_Convoluted_Tubule_Cell_Type_2|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 1.02e-03 | 177 | 50 | 3 | c9e8149639551a4c8daa90fcb2b895fdcff2e2ba | |
| ToppCell | Severe-Myeloid-Neutrophil|Severe / Condition, Lineage, Cell class and cell subclass | 1.04e-03 | 178 | 50 | 3 | 454313efe59d71e7327b9758efabf2d893e4a8fd | |
| ToppCell | Severe-Myeloid-Neutrophil-|Severe / Condition, Lineage, Cell class and cell subclass | 1.04e-03 | 178 | 50 | 3 | 8618ae891d62bf70fe860ff7bb2d31868961aa13 | |
| ToppCell | BALF-PFMC-Severe-critical_progression_d12-22_with-steroid-Lymphocytic-Lymphocytic_T-mature_alpha-beta_T_cell-T_CD8_c01-LEF1|Severe-critical_progression_d12-22_with-steroid / Compartment, severity and other cell annotations on 10x 3' data (130k) | 1.04e-03 | 178 | 50 | 3 | 73936c2e7e8855b4ab65cad425686513dba331a3 | |
| ToppCell | systemic_lupus_erythematosus-treated-Lymphocytic_T-T4_reg-female|systemic_lupus_erythematosus / PBMC cell types (v2) per disease, treatment status, and sex | 1.04e-03 | 178 | 50 | 3 | 90dedb3cef9b01907b9f8eec64218d6d2072be1f | |
| ToppCell | systemic_lupus_erythematosus-treated-Lymphocytic_T-T4_reg|systemic_lupus_erythematosus / PBMC cell types (v2) per disease, treatment status, and sex | 1.04e-03 | 178 | 50 | 3 | d6312286bf6cc5b107ccd7adb583d9667d4e1d21 | |
| ToppCell | ILEUM-non-inflamed-(1)_T_(gd)|non-inflamed / shred on tissue, inflammation_status, cell class(v3), cell subclass (v2) | 1.07e-03 | 180 | 50 | 3 | 44c37644973c4fc555dc966f8cfe1f4f81fef300 | |
| ToppCell | PBMC_fresh-frozen-Severe-critical_progression_d12-22_no-steroids-Lymphocytic-Lymphocytic_T-mature_alpha-beta_T_cell-T_CD4_c06-NR4A2|Severe-critical_progression_d12-22_no-steroids / Compartment, severity and other cell annotations on 10x 3' data (130k) | 1.07e-03 | 180 | 50 | 3 | f3d35b2ea78afef37a84232adf5e6e26712b618d | |
| ToppCell | COVID-19-kidney-NK|COVID-19 / Disease (COVID-19 only), tissue and cell type | 1.09e-03 | 181 | 50 | 3 | 8906ee8a7a1616dfe8c3b5c73988416641213629 | |
| ToppCell | 343B-Lymphocytic-CD4_T-cell-Treg_cell_4|CD4_T-cell / Donor, Lineage, Cell class and subclass (all cells) | 1.13e-03 | 183 | 50 | 3 | 3cbe0175d05fd39bc430de1ef471ff2c5b56460e | |
| ToppCell | 3'_v3-bone_marrow-Lymphocytic_T_CD4/8-lo-Tgd_CRTAM|bone_marrow / Manually curated celltypes from each tissue | 1.13e-03 | 183 | 50 | 3 | 37db007cc65005bffc18a5fda7f454a57c9fb0a9 | |
| ToppCell | CF-Myeloid-Neutrophil|CF / Disease state, Lineage and Cell class | 1.13e-03 | 183 | 50 | 3 | da43827952e6fdee2ce94648c316182f272b321c | |
| ToppCell | PBMC_fresh-frozen-Severe-critical_progression_d12-22_no-steroids-Lymphocytic-Lymphocytic_T-mature_alpha-beta_T_cell-T_CD4_c01-LEF1|Severe-critical_progression_d12-22_no-steroids / Compartment, severity and other cell annotations on 10x 3' data (130k) | 1.13e-03 | 183 | 50 | 3 | f2ef110bf29b1a8276ef216238363e542db262c1 | |
| ToppCell | 3'_v3-bone_marrow-Lymphocytic_T_CD4/8-lo|bone_marrow / Manually curated celltypes from each tissue | 1.13e-03 | 183 | 50 | 3 | 2fb78622adc170dd3301e251418337523de50faf | |
| ToppCell | ILEUM-inflamed-(1)_T_cell-(1)_CD8_Trm|(1)_T_cell / shred on tissue, inflammation_status, cell class(v3), cell subclass (v2) | 1.15e-03 | 184 | 50 | 3 | cef3ee2a4a0af961aa3b4c92150d423e841ae8c1 | |
| ToppCell | 356C-Lymphocytic-CD4_T-cell-Treg_cell_2|CD4_T-cell / Donor, Lineage, Cell class and subclass (all cells) | 1.16e-03 | 185 | 50 | 3 | e06a784a297f357f3f8e761c24fa70722048ab42 | |
| ToppCell | renal_cortex_nuclei-CKD+DKD_normotensive-Immune-Lymphocytic_T/NK|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 1.18e-03 | 186 | 50 | 3 | 9d576dce2c5deefef1adda16c6da7055c8d57f8f | |
| ToppCell | PBMC_fresh-frozen-Severe-critical_progression_d12-22_no-steroids-Lymphocytic-Lymphocytic_T-mature_alpha-beta_T_cell-T_CD4_c05-FOS|Severe-critical_progression_d12-22_no-steroids / Compartment, severity and other cell annotations on 10x 3' data (130k) | 1.18e-03 | 186 | 50 | 3 | c793a3d5709ad504c12fc3b2337746d90236d3ca | |
| ToppCell | renal_cortex_nuclei-CKD+DKD_normotensive-Immune-Lymphocytic_T/NK-T_Cell-|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 1.18e-03 | 186 | 50 | 3 | bd3bd022b575d9b0ef90d50a5cb874085a827b77 | |
| ToppCell | 3'-Adult-SmallIntestine-Epithelial-mature_enterocytic|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.18e-03 | 186 | 50 | 3 | bdd9d3a432aab46e733469b362f0064d35c1ac49 | |
| ToppCell | renal_cortex_nuclei-CKD+DKD_normotensive-Immune-Lymphocytic_T/NK-T_Cell|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 1.18e-03 | 186 | 50 | 3 | 924cc357b4c4ce8e9b05773bdab544f0b65474cc | |
| ToppCell | Smart-seq2-lymph_node_(Smart-seq2)-lymphocytic-T_lymphocytic-effector_CD4-positive,_alpha-beta_T_cell|lymph_node_(Smart-seq2) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type | 1.20e-03 | 187 | 50 | 3 | e61c1755531469dd3850c9740474b5ad4e0499c1 | |
| ToppCell | 3'-Adult-SmallIntestine-Epithelial-mature_enterocytic-Enterocyte|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.20e-03 | 187 | 50 | 3 | 9042bd0f57213a51503d9df2e4dce3209b7772d3 | |
| ToppCell | ILEUM-inflamed-(1)_CD8_Trm|inflamed / shred on tissue, inflammation_status, cell class(v3), cell subclass (v2) | 1.20e-03 | 187 | 50 | 3 | a77d7ae44f47410bd92fb3aa0f44dce891752b63 | |
| ToppCell | PBMC_fresh-frozen-Severe-critical_progression_d12-22_no-steroids-Lymphocytic-Lymphocytic_T-mature_alpha-beta_T_cell-T_CD4_c07-AHNAK|Severe-critical_progression_d12-22_no-steroids / Compartment, severity and other cell annotations on 10x 3' data (130k) | 1.20e-03 | 187 | 50 | 3 | e1d6c1194476cf26969e405b0951796fed519f44 | |
| ToppCell | Fetal_29-31_weeks-Immune-natural_killer_cell-D088|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 1.22e-03 | 188 | 50 | 3 | 6686dbba990066568aa7573e70a7db8b4758f457 | |
| ToppCell | COPD-Lymphoid-NK|COPD / Disease state, Lineage and Cell class | 1.22e-03 | 188 | 50 | 3 | c9a227c8e71b69929d43e9afb8306a95c8163778 | |
| ToppCell | PBMC-Severe-Myeloid-Neutrophil-Neutrophil-Neu_1|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 1.22e-03 | 188 | 50 | 3 | aa46073e2940dc1d2020b2e259bf0fc06cb990ee | |
| ToppCell | PBMC-Severe-Myeloid-Neutrophil-Neutrophil-Neu_1|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09) | 1.22e-03 | 188 | 50 | 3 | 04814b78da936a51a497e23060d19ca0d619e250 | |
| ToppCell | systemic_lupus_erythematosus-flare-Lymphocytic_T-T4_reg|systemic_lupus_erythematosus / PBMC cell types (v2) per disease, treatment status, and sex | 1.22e-03 | 188 | 50 | 3 | e5c480b9a030536578f1cc91fb61738f752525b3 | |
| Disease | Agammaglobulinemia, non-Bruton type | 7.21e-05 | 8 | 48 | 2 | C1832241 | |
| Disease | Agammaglobulinemia | 1.69e-04 | 12 | 48 | 2 | C0001768 | |
| Disease | unipolar depression | 6.70e-04 | 1206 | 48 | 8 | EFO_0003761 | |
| Disease | macular telangiectasia type 2 | 8.21e-04 | 26 | 48 | 2 | EFO_1002009 | |
| Disease | verbal-numerical reasoning measurement | 1.28e-03 | 131 | 48 | 3 | EFO_0008394 | |
| Disease | personality trait | 1.85e-03 | 39 | 48 | 2 | EFO_0004365 | |
| Disease | glucagon measurement | 2.03e-03 | 154 | 48 | 3 | EFO_0008463 | |
| Disease | unipolar depression, bipolar disorder | 2.11e-03 | 156 | 48 | 3 | EFO_0003761, MONDO_0004985 | |
| Disease | complement factor H-related protein 5 measurement | 2.14e-03 | 42 | 48 | 2 | EFO_0008098 | |
| Disease | developmental disorder of mental health (implicated_via_orthology) | 2.90e-03 | 49 | 48 | 2 | DOID:0060037 (implicated_via_orthology) | |
| Disease | macula measurement | 3.62e-03 | 189 | 48 | 3 | EFO_0008375 | |
| Disease | feeling emotionally hurt measurement | 3.77e-03 | 56 | 48 | 2 | EFO_0009599 | |
| Disease | polycystic ovary syndrome | 4.32e-03 | 60 | 48 | 2 | EFO_0000660 | |
| Disease | anxiety | 5.73e-03 | 223 | 48 | 3 | EFO_0005230 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| PQWLTHLLYYAEFLF | 501 | Q15878 | |
| WPHLQLVYEFFLRFL | 131 | Q13362 | |
| KILFHLSDYFIVQWP | 186 | Q96F25 | |
| LYFNPHLVFRKFQVW | 41 | Q96Q80 | |
| HSVILFWFPLKALQY | 951 | Q9Y2Q0 | |
| YLPHTFWITLLDAFY | 1191 | Q9P241 | |
| VLLWIYKKFLEPYIY | 11 | Q8TCD1 | |
| IINIYIYPFAHWLAF | 411 | Q9Y5X5 | |
| NRLHWFAKYFPYLVL | 116 | Q8IWT6 | |
| YYWHVIAAKLAFIIV | 826 | Q4KMQ2 | |
| EWYGYHFPELVKIIN | 191 | O00567 | |
| LTEKANHYYKLFIPW | 271 | Q5TA45 | |
| PLAFGLFNIVYWVYH | 616 | Q9UN88 | |
| IPEVSSVWFKLYIYH | 526 | Q658Y4 | |
| ILFIPVKYWHYVRAL | 391 | Q8N371 | |
| WKLFLEQHYPYFLIV | 131 | Q5H9U9 | |
| LHWYAKYFPYLVVIH | 111 | Q6NSJ5 | |
| YWLTLQYLLKHFFKL | 236 | P27986 | |
| WFAKFFPYLVLLHTL | 116 | Q6P9F7 | |
| YEEQHLYFYKVWLPL | 296 | A8MWK0 | |
| FFQKAYAPFLLHWIT | 831 | Q9UHC9 | |
| IIFPAAYILFNLIYW | 461 | P24046 | |
| PHIKPEWYFLFAYTI | 266 | P00156 | |
| PVKDIYNWILEHFPY | 136 | O00409 | |
| YTFSLLDHLPYFIKW | 186 | B0YJ81 | |
| LDHLPYFIKWARYNF | 191 | B0YJ81 | |
| SYLAIFWILQPLFVY | 21 | Q58HT5 | |
| SYLPWFEVFYKLLNI | 101 | Q8TEH3 | |
| KEIYSWILDHFPYFA | 136 | P32314 | |
| LNPLIYYWRIKKFHD | 366 | Q9BZJ6 | |
| PKEIYEHYFVFAAIW | 2366 | Q9NYC9 | |
| LYFNPELIFKHFQIW | 41 | Q9GZP9 | |
| LPWFEVYYKLLNTLA | 101 | Q6P3S1 | |
| VLTFAICWLPYHLYF | 256 | P21452 | |
| PHPYAIAVFKNEIYW | 961 | Q92673 | |
| LIYLRYVPLWKVHIF | 1071 | Q9Y6M7 | |
| LALHYFPEYQWLVDF | 96 | Q8NDZ6 | |
| PKWPYFIQYKHFSLF | 1861 | A0AVI2 | |
| WIIEVLNLQPFYFYK | 521 | P28749 | |
| YSLFLPLHELWKQYI | 96 | O95707 | |
| IYHPAFIKYVFDNWL | 246 | Q11201 | |
| YELKIAFVIWLLSPY | 66 | Q6NUK4 | |
| WPHIQLVYEFFLRFL | 156 | Q15172 | |
| LYSFAIHRYIPFILW | 131 | Q8TAZ6 | |
| YHTPWYLFELFPFIL | 381 | P51790 | |
| PWYIHALYTLIKPFL | 226 | Q8IUQ0 | |
| LLFFPYLHQDWEVQY | 126 | Q5BJH7 | |
| YIPLIHFKIRLAWFE | 436 | Q8TCU3 | |
| IPFLPHAWKYIAYVV | 61 | Q9H8X9 | |
| KLLAKYQEIPFYHVW | 756 | O95185 | |
| HWYAKYFPYLVLIHT | 121 | Q8TDW0 | |
| WAPVVAIYFILYHLF | 571 | Q8IZF0 |